Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 33
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
After the Readout: How the Field Is Interpreting Compass’ Phase 3 Psilocybin Data
Q1’26 Psychedelic Drug Development Pipeline: Bullseye Charts
Compass Provides Fuller Phase 3 Picture, MADRS Curves, on Webcast
BREAKING: Second Positive Phase 3 for Compass’ Psilocybin, Though Modest Magnitude Raises Questions
AtaiBeckley Seeks Partner for BPL-003 as Pharma Interest Builds After AbbVie-Gilgamesh Deal
Billionaire Investor Antonio Gracias Plots $100M Lykos Takeover with Doblin’s Backing
Can Legalization Serve the Greater Good? The Ethical Challenges of Psychedelic...
From Fringe to Focus: APA’s American Journal of Psychiatry Publishes Special...
Natural Medicine Advisory Bulletin 15: A Duplicitous December
Pot for the People: Debunking Cannabis Myths and Empowering Consumers
How Psychedelics Can Help Build a Better You: The Power in...
Pα+ Psychedelic Bulletin #184: Federal Psychedelics Lobbying Jumps 90% in Q3’24,...
Taking the Leap: Skydiving, Psychedelics, and Unlocking Personal Potential
Psychedelic Alpha’s Top 11 Stories from 2024
Rethinking Addiction and Treatment Models: Is the Recovery Community Ready for...
Load more